Anne Roemer-Mahler
Biographic Data
| ID | 1310728 |
|---|---|
| NAME | Anne Roemer-Mahler |
| GIVEN NAMES | Anne |
| FAMILY NAME | Roemer-Mahler |
| SIGNATURE | ROEMER-MAHLER A |
| AFFILIATIONS | University of Sussex |
| ORCID | 0000-0002-3016-3973 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 73 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 5 |
Making space for happenstance
Historically, neglected tropical diseases (NTDs) have received far less global attention than the ‘big three’ diseases of global health (HIV, TB, and malaria), reinforcing health inequities experienced by those affected. Policy advocacy has been a necessary part of the work of NTD specialists, including researchers. One commonly used tool to support planned change is Theory of Change (ToC), employed by organisations such as the World Health Organ…
The International Politics of Ebola
From security to risk
The rise of health issues such as HIV, pandemic influenza and Ebola on international agendas has led to the framing of threats to health as security issues. This has created an uneasy relationship between politics and health, by moving national interests into an area traditionally dominated by scientific rationalities and a predisposition towards cosmopolitan norms. Framing global health threats as risks, however, appears to be less politically c…
The race for Ebola drugs
The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines. This article identifies three mechanisms that interlink these trends. First, securitisation encourages technological policy responses. Second, it creates an exceptional political space in which pharmaceutical development can…
Introduction
The outbreak of Ebola Virus Disease (EVD) that gripped Liberia, Guinea and Sierra Leone through much of 2014 and 2015 was an enormous and in many ways unprecedented health emergency. Yet the outbreak was not only a global health event – it was also a global political event. In this introduction to the special issue we discuss the contribution that International Relations scholarship can make to analysing and understanding the Ebola outbreak and t…
Medical countermeasures for national security
How do governments contribute to the pharmaceuticalization of society? Whilst the pivotal role of industry is extensively documented, this article shows that governments too are accelerating, intensifying and opening up new trajectories of pharmaceuticalization in society. Governments are becoming more deeply invested in pharmaceuticals because their national security strategies now aspire to defend populations against health-based threats like b…
Understanding Global Health Governance
Securing circulation pharmaceutically
Governments in Europe and around the world amassed vast pharmaceutical stockpiles in anticipation of a potentially catastrophic influenza pandemic. Yet the comparatively 'mild' course of the 2009 H1N1 pandemic provoked considerable public controversy around those stockpiles, leading to questions about their cost-benefit profile and the commercial interests allegedly shaping their creation, as well as around their scientific evidence base. So, how…
The rise of companies from emerging markets in global health governance
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies. In so doing, pharmaceutical companies from emerging markets have facilitated the implementation of a key goal of global health policy: widening access to pharmaceutical treatment and prevention. Yet, looking cl…
Framing global health
With the emergence of global health comes governance challenges which are equally global in nature. This article identifies some of the initial limitations in analyses of global health governance (GHG) before discussing the focus of this special supplement: the framing of global health issues and the manner in which this impacts upon GHG. Whilst not denying the importance of material factors (such as resources and institutional competencies), the…
Business conflict and global politics
Most existing studies on the role of business in global governance conceive of business as one group acting vis-à-vis the state or NGOs. This article highlights that conflicts within the business community can be an important factor to explain policy outcomes. Drawing on the ‘business conflict school’ literature from International Relations, studies on the politics of markets developed in Economic Sociology, and work on corporate political strate…
Securing circulation pharmaceutically
Governments in Europe and around the world amassed vast pharmaceutical stockpiles in anticipation of a potentially catastrophic influenza pandemic. Yet the comparatively 'mild' course of the 2009 H1N1 pandemic provoked considerable public controversy around those stockpiles, leading to questions about their cost-benefit profile and the commercial interests allegedly shaping their creation, as well as around their scientific evidence base. So, how…
Business conflict and global politics
Most existing studies on the role of business in global governance conceive of business as one group acting vis-à-vis the state or NGOs. This article highlights that conflicts within the business community can be an important factor to explain policy outcomes. Drawing on the ‘business conflict school’ literature from International Relations, studies on the politics of markets developed in Economic Sociology, and work on corporate political strate…
The race for Ebola drugs
The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines. This article identifies three mechanisms that interlink these trends. First, securitisation encourages technological policy responses. Second, it creates an exceptional political space in which pharmaceutical development can…
Medical countermeasures for national security
How do governments contribute to the pharmaceuticalization of society? Whilst the pivotal role of industry is extensively documented, this article shows that governments too are accelerating, intensifying and opening up new trajectories of pharmaceuticalization in society. Governments are becoming more deeply invested in pharmaceuticals because their national security strategies now aspire to defend populations against health-based threats like b…
From security to risk
The rise of health issues such as HIV, pandemic influenza and Ebola on international agendas has led to the framing of threats to health as security issues. This has created an uneasy relationship between politics and health, by moving national interests into an area traditionally dominated by scientific rationalities and a predisposition towards cosmopolitan norms. Framing global health threats as risks, however, appears to be less politically c…
The rise of companies from emerging markets in global health governance
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies. In so doing, pharmaceutical companies from emerging markets have facilitated the implementation of a key goal of global health policy: widening access to pharmaceutical treatment and prevention. Yet, looking cl…
Introduction
The outbreak of Ebola Virus Disease (EVD) that gripped Liberia, Guinea and Sierra Leone through much of 2014 and 2015 was an enormous and in many ways unprecedented health emergency. Yet the outbreak was not only a global health event – it was also a global political event. In this introduction to the special issue we discuss the contribution that International Relations scholarship can make to analysing and understanding the Ebola outbreak and t…
Framing global health
With the emergence of global health comes governance challenges which are equally global in nature. This article identifies some of the initial limitations in analyses of global health governance (GHG) before discussing the focus of this special supplement: the framing of global health issues and the manner in which this impacts upon GHG. Whilst not denying the importance of material factors (such as resources and institutional competencies), the…
Business conflict and global politics
Most existing studies on the role of business in global governance conceive of business as one group acting vis-à-vis the state or NGOs. This article highlights that conflicts within the business community can be an important factor to explain policy outcomes. Drawing on the ‘business conflict school’ literature from International Relations, studies on the politics of markets developed in Economic Sociology, and work on corporate political strate…
Understanding Global Health Governance
Securing circulation pharmaceutically
Governments in Europe and around the world amassed vast pharmaceutical stockpiles in anticipation of a potentially catastrophic influenza pandemic. Yet the comparatively 'mild' course of the 2009 H1N1 pandemic provoked considerable public controversy around those stockpiles, leading to questions about their cost-benefit profile and the commercial interests allegedly shaping their creation, as well as around their scientific evidence base. So, how…
The rise of companies from emerging markets in global health governance
The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies. In so doing, pharmaceutical companies from emerging markets have facilitated the implementation of a key goal of global health policy: widening access to pharmaceutical treatment and prevention. Yet, looking cl…
Medical countermeasures for national security
How do governments contribute to the pharmaceuticalization of society? Whilst the pivotal role of industry is extensively documented, this article shows that governments too are accelerating, intensifying and opening up new trajectories of pharmaceuticalization in society. Governments are becoming more deeply invested in pharmaceuticals because their national security strategies now aspire to defend populations against health-based threats like b…
The race for Ebola drugs
The international Ebola response mirrors two broader trends in global health governance: (1) the framing of infectious disease outbreaks as a security threat; and (2) a tendency to respond by providing medicines and vaccines. This article identifies three mechanisms that interlink these trends. First, securitisation encourages technological policy responses. Second, it creates an exceptional political space in which pharmaceutical development can…
Introduction
The outbreak of Ebola Virus Disease (EVD) that gripped Liberia, Guinea and Sierra Leone through much of 2014 and 2015 was an enormous and in many ways unprecedented health emergency. Yet the outbreak was not only a global health event – it was also a global political event. In this introduction to the special issue we discuss the contribution that International Relations scholarship can make to analysing and understanding the Ebola outbreak and t…
From security to risk
The rise of health issues such as HIV, pandemic influenza and Ebola on international agendas has led to the framing of threats to health as security issues. This has created an uneasy relationship between politics and health, by moving national interests into an area traditionally dominated by scientific rationalities and a predisposition towards cosmopolitan norms. Framing global health threats as risks, however, appears to be less politically c…
The International Politics of Ebola
Making space for happenstance
Historically, neglected tropical diseases (NTDs) have received far less global attention than the ‘big three’ diseases of global health (HIV, TB, and malaria), reinforcing health inequities experienced by those affected. Policy advocacy has been a necessary part of the work of NTD specialists, including researchers. One commonly used tool to support planned change is Theory of Change (ToC), employed by organisations such as the World Health Organ…
Political science (10 works) · Global Security and Public Health (8 works) · Law (8 works) · Politics (7 works) · Economics (6 works) · Law (6 works) · Business (5 works) · Corporate governance (5 works) · Global health (5 works) · Health care (5 works)